Fund Holdings — BVF INC/IL

Total Portfolio Value
$2.47B
Total Bought
$487.37M
Total Sold
$339.46M
Net Transaction
+$147.91M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CIDARA THERAPEUTICS INC786,3921,414,165+627,77338,305135,4205.49%+97,115
NEKTAR THERAPEUTICS(NKTR)01,276,595+1,276,595072,6382.94%+72,638
KYMERA THERAPEUTICS INC(KYMR)5,502,7105,502,7100240,138311,45312.63%+71,315
PALVELLA THERAPEUTICS INC NE(PVLA)696,5551,161,249+464,69415,70072,7992.95%+57,098
STRUCTURE THERAPEUTICS INC1,771,4173,203,917+1,432,50036,73989,7103.64%+52,970
ABIVAX SA(ABVX)0558,031+558,031047,3771.92%+47,377
STOKE THERAPEUTICS INC(STOK)01,657,096+1,657,096038,9421.58%+38,942
XOMA ROYALTY CORPORATION2,590,3032,590,303065,27699,8304.05%+34,555
KURA ONCOLOGY INC(KURA)7,754,1298,617,162+863,03344,74176,2623.09%+31,521
OLEMA PHARMACEUTICALS INC(OLMA)5,295,8935,295,893022,56151,8472.10%+29,286
SEPTERNA INC(SEPN)4,396,1244,015,790-380,33446,46775,5373.06%+29,070
IMMUNOCORE HLDGS PLC(IMCR)1,024,2881,574,288+550,00032,14257,1942.32%+25,052
4D MOLECULAR THERAPEUTICS IN4,629,2894,629,289017,17540,2291.63%+23,054
GH RESEARCH PLC(GHRS)8,827,7128,827,7120107,610126,2365.12%+18,626
AC IMMUNE SA(ACIU)19,822,43619,822,436040,24057,2872.32%+17,047
COMPASS THERAPEUTICS INC(CMPX)04,750,000+4,750,000016,6250.67%+16,625
MONTE ROSA THERAPEUTICS INC(GLUE)5,660,1325,660,132025,52741,9421.70%+16,414
TYRA BIOSCIENCES INC(TYRA)3,944,1943,649,794-294,40037,74651,0612.07%+13,315
ZYMEWORKS INC(ZYME)4,308,9353,938,641-370,29454,07767,2722.73%+13,195
AVALO THERAPEUTICS INC(AVTX)1,028,0491,355,256+327,2075,13017,2250.70%+12,095
XENCOR INC(XNCR)2,740,1412,740,141021,53832,1421.30%+10,604
PEPGEN INC(PEPG)01,915,000+1,915,00008,8470.36%+8,847
X4 PHARMACEUTICALS INC(XFOR)02,233,742+2,233,74207,6390.31%+7,639
IMAGENEBIO INC(IMA)0802,102+802,10206,5370.26%+6,537
ANNEXON INC(ANNX)7,000,0007,000,000016,80021,3500.87%+4,550
REPARE THERAPEUTICS INC10,333,60010,333,600014,36418,1870.74%+3,823
REVOLUTION MEDICINES INC(RVMD)4,982,3843,974,913-1,007,471183,302185,6287.52%+2,327
TSCAN THERAPEUTICS INC(TCRX)5,226,0745,226,07407,5789,5110.39%+1,934
INVENTIVA SA(IVA)686,040686,04002,1403,9720.16%+1,832
IMMUNIC INC(IMUX)7,652,9727,652,97205,3386,7470.27%+1,409
FOGHORN THERAPEUTICS INC(FHTX)5,302,0005,302,000024,91925,9271.05%+1,007
TENAX THERAPEUTICS INC(TENX)339,549339,54901,9832,5840.10%+601
SAB BIOTHERAPEUTICS INC(SABS)917,826932,697+14,8711,6061,8750.08%+269
ENGENE HOLDINGS INC
*W EXP 10/31/202
945,402945,40205866810.03%+95
NLS PHARMACEUTICS LTD143,676143,67604172630.01%-154
MOLECULAR PARTNERS AG(MOLN)1,353,9681,353,96805,1865,0230.20%-162
ELEDON PHARMACEUTICALS INC(ELDN)6,293,2826,293,282017,05516,3000.66%-755
OVID THERAPEUTICS INC(OVID)3,853,8180-3,853,8181,2710—-1,271
IKENA ONCOLOGY INC4,006,5640-4,006,5645,3690—-5,369
CRESCENT BIOPHARMA INC.(CBIO)1,387,8631,387,863022,40016,5020.67%-5,898
FORTE BIOSCIENCES INC(FBRX)588,34465,350-522,9947,6079800.04%-6,627
PROTAGONIST THERAPEUTICS INC3,211,0412,560,916-650,125177,474170,1226.90%-7,353
CULLINAN THERAPEUTICS INC(CGEM)5,750,6835,750,683043,30334,1021.38%-9,201
RAPT THERAPEUTICS INC1,154,6920-1,154,6929,2380—-9,238
ESSA PHARMA INC8,748,62911,668,473+2,919,84414,8732,2290.09%-12,644
CELCUITY INC(CELC)3,466,000658,421-2,807,57946,27132,5261.32%-13,745
VERASTEM INC(VSTM)3,404,4250-3,404,42514,1280—-14,128
MIRUM PHARMACEUTICALS INC(MIRM)2,761,3331,495,290-1,266,043140,524109,6204.44%-30,905
IONIS PHARMACEUTICALS INC(IONS)1,913,3850-1,913,38575,5980—-75,598
AXSOME THERAPEUTICS INC(AXSM)1,690,221486,757-1,203,464176,44259,1172.40%-117,326
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)19,751,28419,751,2840932,261141,6175.74%-790,644
Page 1 of 1
BVF INC/IL — 13F Holdings — Q3 2025 | TickerTrail